Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer.

Zuo Z, Zhou Z, Chang Y, Liu Y, Shen Y, Li Q, Zhang L

Open source

DOI
10.1016/j.gendis.2022.11.022
Published
2024 Jan
Container
Genes & diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.gendis.2022.11.022,
  title = {Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer.},
  author = {Zuo Z and Zhou Z and Chang Y and Liu Y and Shen Y and Li Q and Zhang L},
  year = {2024},
  journal = {Genes \& diseases},
  doi = {10.1016/j.gendis.2022.11.022},
  url = {https://doi.org/10.1016/j.gendis.2022.11.022}
}

RIS

TY  - JOUR
TI  - Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer.
AU  - Zuo Z
AU  - Zhou Z
AU  - Chang Y
AU  - Liu Y
AU  - Shen Y
AU  - Li Q
AU  - Zhang L
PY  - 2024
JO  - Genes & diseases
DO  - 10.1016/j.gendis.2022.11.022
UR  - https://doi.org/10.1016/j.gendis.2022.11.022
ER  - 

APA

Z, Z., Z, Z., Y, C., Y, L., Y, S., Q, L., & L, Z. (2024). Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer.. Genes & diseases. https://doi.org/10.1016/j.gendis.2022.11.022

Source records